SCHEMBL22987290

SCHEMBL22987290

CNCC(=O)NC(Cc1ccccc1)C(=O)NCCN1C(=O)C=CC1=O

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKT1 P31749 1/20 0.69
CTSS P25774 4/20 0.48
CTSL P07711 4/20 0.48
CTSB P07858 2/20 0.48
L3MBTL1 Q9Y468 1/20 0.46
CHRNB2 P17787 1/20 0.45
CHRNB4 P30926 1/20 0.45
CHRNA3 P32297 1/20 0.45
CHRNA4 P43681 1/20 0.45
HDAC3 O15379 1/20 0.45
HDAC4 P56524 1/20 0.45
HDAC1 Q13547 1/20 0.45
HDAC7 Q8WUI4 1/20 0.45
HDAC2 Q92769 1/20 0.45
HDAC10 Q969S8 1/20 0.45
HDAC11 Q96DB2 1/20 0.45
HDAC8 Q9BY41 1/20 0.45
HDAC6 Q9UBN7 1/20 0.45
HDAC9 Q9UKV0 1/20 0.45
HDAC5 Q9UQL6 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22915402 0.89 AKT1 (0.70) AKT1CTSSCTSLCTSBL3MBTL1
SCHEMBL22915375 0.89 AKT1 (0.70) AKT1CTSSCTSLCTSBL3MBTL1
SCHEMBL22987210 0.89 AKT1 (0.55) AKT1CTSSCHRNB2CHRNB4CHRNA3
SCHEMBL22987323 0.89 AKT1 (0.66) AKT1CTSSCTSLCTSBL3MBTL1
SCHEMBL22915395 0.87 AKT1 (0.67) AKT1CTSSCTSLCTSBL3MBTL1
SCHEMBL22987322 0.87 AKT1 (0.69) AKT1CTSSCTSLCTSBL3MBTL1
SCHEMBL22915441 0.86 AKT1 (0.83) AKT1CTSSCTSLCTSBCTSK
SCHEMBL28767105 0.86 AKT1 (0.83) AKT1CTSSCTSLCTSBCTSK
Trifluoroacetic Acid SCHEMBL22973518 0.83 AKT1 (0.67) AKT1CTSSCTSLCTSBL3MBTL1
Trifluoroacetic Acid SCHEMBL22973515 0.83 AKT1 (0.67) AKT1CTSSCTSLCTSBL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3778653-A1 NOVEL REACTIVE ALGINIC ACID DERIVATIVES Mochida Pharmaceutical Co., Ltd. (JP) 2021-02-17 EP disclosed